The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Open accessAbstract
Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed exome sequencing and copy number analysis to define genomic aberrations in a prospectively accrued clinical cohort (n = 142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma. Detailed analysis of 99 informative tumours identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-number variations. We define 16 significantly mutated genes, reaffirming known mutations (KRAS, TP53, CDKN2A, SMAD4, MLL3, TGFBR2, ARID1A and SF3B1), and uncover novel mutated genes including additional genes involved in chromatin modification (EPC1 and ARID2), DNA damage repair (ATM) and other mechanisms (ZIM2, MAP2K4, NALCN, SLC16A4 and MAGEA6). Integrative analysis with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis. Pathway-based analysis of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway. We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the identified genomic alterations (GAs) in PDAC, oncogenic KRAS mutations are the most common, occurring in close to 90% of patients, followed by TP53, CDKN2A, and SMAD47,8.”
From Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma (2024) · cites this paper as [7]
In the citing paper
“Amongst these are four canonical mutations – KRAS (~85%), TP53 (60–70%), CDKN2A (>50%), and SMAD4 (~50%).”
From KRAS mutation in pancreatic cancer (2021) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,432
Brocken, P., van der Heijden, E. H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus‐Oei, L. (2013) · Respiration · doi:10.1159/000347096 · Cited by 4,011
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationMermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,520
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
Self-citationNeoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M. J., Gallinger, S., Mariette, C., et al. (2010) · JAMA · doi:10.1001/jama.2010.1275 · Cited by 1,395
Self-citationThe patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Self-citationExome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Varela, I., Tarpey, P. S., Raine, K. M., Huang, D., Ong, C. K., Stephens, P., Davies, H. R., Jones, D., Lin, M., Teague, J. W., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,302
Self-citation
Cited by
Sorted by citations
Items 601–700 of 1,002
Lu, J., Dong, Q., Zhang, B., Wang, X., Ye, B., Zhang, F., Song, X., Gao, G., Mu, J., Wang, Z., et al. (2015) · Medical Oncology · doi:10.1007/s12032-015-0616-9 · Cited by 49
RetractedOvercoming treatment resistance in cancer: Current understanding and tactics
Wu, G. J., Wilson, G., George, J., Liddle, C., Hebbard, L., & Qiao, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.018 · Cited by 49
Gundry, C., Marco, S., Rainero, E., Miller, B., Dornier, E., Mitchell, L. E., Caswell, P. T., Campbell, A. D., Hogeweg, A., Sansom, O. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14646 · Cited by 49
Drosos, Y., Escobar, D., Chiang, M.-Y., Roys, K., Valentine, V. A., Valentine, M. B., Rehg, J. E., Sahai, V., Begley, L., Ye, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11661-8 · Cited by 51
Epithelial-Stromal Interactions in Pancreatic Cancer
Zhang, Y., Crawford, H. C., & di Magliano, M. P. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114515 · Cited by 52
Alternative splicing and cancer metastasis: prognostic and therapeutic applications
Marzese, D. M., Manughian-Peter, A. O., Orozco, J. I. J., & Hoon, D. S. �. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9905-y · Cited by 47
Liu, D., Ma, X., Yang, F., Xiao, D., Jia, Y., & Wang, Y. (2019) · Cancer Gene Therapy · doi:10.1038/s41417-019-0125-7 · Cited by 48
Pancreatic Fibroblast Heterogeneity: From Development to Cancer
Garcia, P. E., Scales, M. K., Allen, B. L., & di Magliano, M. P. (2020) · Cells · doi:10.3390/cells9112464 · Cited by 48
Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment
Yamamoto, K., Iwadate, D., Kato, H., Nakai, Y., Tateishi, K., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14184351 · Cited by 52
Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
Taherian, M., Wang, H., & Wang, H. (2022) · Cells · doi:10.3390/cells11193068 · Cited by 52
New insights into the physiology and pathophysiology of the atypical sodium leak channel NALCN
Monteil, A., Guérineau, N. C., Gil‐Nagel, A., Parra‐Díaz, P., Lory, P., & Senatore, A. (2023) · Physiological Reviews · doi:10.1152/physrev.00014.2022 · Cited by 49
Fanale, D., Iovanna, J., Calvo, E. L., Berthézène, P., Belleau, P., Dagorn, J. C., Bronte, G., Cicero, G., Bazan, V., Rolfo, C. D., et al. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.920324 · Cited by 49
Germline mutations in pancreatic cancer and potential new therapeutic options
Pihlak, R., Valle, J. W., & McNamara, M. G. (2017) · Oncotarget · doi:10.18632/oncotarget.17291 · Cited by 48
Walsh, A. J., Cook, R. S., & Skala, M. C. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.192534 · Cited by 48
Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer
Berger, A. W., Schwerdel, D., Ettrich, T. J., Hann, A., Schmidt, S. A., Kleger, A., Marienfeld, R. B., & Seufferlein, T. T. W. (2017) · Oncotarget · doi:10.18632/oncotarget.23330 · Cited by 48
Hata, T., Suenaga, M., Marchionni, L., Macgregor-Das, A. M., Yu, J., Shindo, K., Tamura, K., Hruban, R. H., & Goggins, M. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.03.012 · Cited by 49
Self-citationHu, H., Tu, W., Chen, Y., Zhu, M., Jin, H., Huang, T., Zou, Z., & Xia, Q. (2020) · Journal of Cancer · doi:10.7150/jca.38981 · Cited by 48
Huang, B., Trujillo, M. A. M., Fujikura, K., Qiu, M., Chen, F., Felsenstein, M., Zhou, C., Skaro, M. F., Gauthier, C. D., Macgregor‐Das, A. M., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5515 · Cited by 48
Self-citationIntrinsically disordered proteins: Ensembles at the limits of Anfinsen's dogma
Kulkarni, P., Leite, V. B. P., Roy, S., Bhattacharyya, S., Mohanty, A. R., Achuthan, S., Singh, D., Appadurai, R., Govindan Rangarajan, C., Weninger, K., et al. (2022) · Biophysics Reviews · doi:10.1063/5.0080512 · Cited by 49
Nusrat, F., Khanna, A., Jain, A., Jiang, W., Lavu, H., Yeo, C. J., Bowne, W. B., & Nevler, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072103 · Cited by 55
USP33, a new player in lung cancer, mediates Slit-Robo signaling
Wen, P., Kong, R., Liu, J., Zhu, L., Chen, X., Li, X., Nie, Y., Wu, K., & Wu, J. Y. (2014) · Protein & Cell · doi:10.1007/s13238-014-0070-z · Cited by 47
Self-citationGenetic and molecular alterations in pancreatic cancer: Implications for personalized medicine
Chen, C. (2013) · Medical Science Monitor · doi:10.12659/msm.889636 · Cited by 48
Tang, H., Wei, P., Duell, E. J., Risch, H. A., Olson, S. H., Bueno-de-Mesquita, H. B., Gallinger, S., Holly, E. A., Petersen, G. M., Bracci, P. M., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu010 · Cited by 47
Self-citationKameta, E., Sugimori, K., Kaneko, T., Ishii, T., Miwa, H., Sato, T. A., Ishii, Y., Sue, S., Sasaki, T., Yamashita, Y., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.5168 · Cited by 47
Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma
Llop, E., Guerrero, P. E., Duran, A., Barrabés, S., Massaguer, A., Ferri, M. J., Albiol-Quer, M., Llorens, R., & Peracaula, R. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i24.2537 · Cited by 47
NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB
Kabacaoğlu, D., Ruess, D. A., Ai, J., & Algül, H. (2019) · Cancers · doi:10.3390/cancers11070937 · Cited by 49
Li, F., Dai, L., & Niu, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29391 · Cited by 47
Barsotti, A. M., Ryskin, M., Zhong, W., Zhang, W., Giannakou, A., Loreth, C., Diesl, V., Follettie, M. T., Golas, J., Lee, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2758 · Cited by 46
Next-generation therapies for pancreatic cancer
Buckley, C. W., & O'Reilly, E. M. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2322648 · Cited by 49
Kumar, A., Rao, A., Bhavani, S., Newberg, J. Y., & Murphy, R. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415120112 · Cited by 45
Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy
Hahn, C. N., Venugopal, P., Scott, H. S., & Hiwase, D. (2014) · Immunological Reviews · doi:10.1111/imr.12241 · Cited by 46
Cui, Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5493 · Cited by 46
Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways
Kongpetch, S., Jusakul, A., Ong, C. K., Lim, W. K., Rozen, S., Tan, P. B. O., & Teh, B. T. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.02.002 · Cited by 46
DNA Sequencing of Cancer: What Have We Learned?
Chmielecki, J., & Meyerson, M. M. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-060712-200152 · Cited by 48
Jun, I., Park, H. S., Piao, H., Han, J. W., An, M. J., Yun, B. G., Zhang, X., Cha, Y. H., Shin, Y. K., Yook, J. I., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.355 · Cited by 46
Dependence receptors – the dark side awakens
Negulescu, A., & Mehlen, P. (2018) · FEBS Journal · doi:10.1111/febs.14507 · Cited by 58
López‐Janeiro, Á., Ruz‐Caracuel, I., Ramón-Patiño, J. L., Rı́os, V. D. L., Villalba-Esparza, M., Berjón, A., Yébenes, L., Hernández, A., Masetto, I., Kadioglu, E., et al. (2021) · Cancers · doi:10.3390/cancers13040794 · Cited by 46
Kattan, W. E., Liu, J., Montufar‐Solis, D., Hong, L., Barathi, B. B., van der Hoeven, R., Zhou, Y., & Hancock, J. F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114126118 · Cited by 45
Allelic Ratio of KRAS Mutations in Pancreatic Cancer
Lennerz, J. K., & Stenzinger, A. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0408 · Cited by 46
Small molecule inhibitors in pancreatic cancer
Sun, J., Russell, C. C., Scarlett, C. J., & McCluskey, A. (2020) · RSC Medicinal Chemistry · doi:10.1039/c9md00447e · Cited by 45
Self-citationPapargyriou, A., Najajreh, M., Cook, D. P., Maurer, C. H., Bärthel, S., Messal, H. A., Ravichandran, S. K., Richter, T., Knolle, M. A., Metzler, T., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01273-9 · Cited by 45
Chen, Z., Zhou, Y., Xue, C., Zeng, L., Deng, S., Xu, Z., Li, M., Zhao, H., He, X., Liu, S., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01667-0 · Cited by 53
Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer
Tanaka, S. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4463-x · Cited by 45
Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia
Matsunawa, M., Yamamoto, R., Sanada, M., Sato‐Otsubo, A., Shiozawa, Y., Yoshida, K., Otsu, M., Shiraishi, Y., Miyano, S., Isono, K., et al. (2014) · Leukemia · doi:10.1038/leu.2014.73 · Cited by 49
Adenocarcinoma of the pancreas
Hruban, R. H., & Klimstra, D. S. (2014) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2014.08.004 · Cited by 47
Self-citationMoatassim-Billah, S., Duluc, C., Samain, R., Jean, C., Perraud, A., Decaup, E., Cassant‐Sourdy, S., Bakri, Y., Sèlves, J., SCHMID, H. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9296 · Cited by 45
Sinn, M., Sinn, B. V., Treue, D., Keilholz, U., Damm, F., Schmuck, R. B., Lohneis, P., Klauschen, F., Striefler, J. K., Bahra, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3034 · Cited by 45
A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer
Shinjo, K., Hara, K., Nagae, G., Umeda, T., Katsushima, K., Suzuki, M. M., Murofushi, Y., Umezu, Y., Takeuchi, I., Takahashi, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233782 · Cited by 45
Targeting BRD9 for Cancer Treatment: A New Strategy
Zhu, X., Liao, Y., & Tang, L. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s286867 · Cited by 45
Zhou, M., Yuan, J., Deng, Y., Fan, X., & Shen, J. (2021) · Oncogenesis · doi:10.1038/s41389-020-00296-6 · Cited by 49
Wang, Y., Alla, V., Goody, D., Gupta, S. K., Spitschak, A., Olaf Wolkenhauer, A., Pützer, B. M., & Engelmann, D. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv885 · Cited by 45
Biankin, A. V., & Maitra, A. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.020 · Cited by 45
Self-citationMEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
Smida, M., Fece de la Cruz, F., Kerzendorfer, C., Uras, I. Z., Mair, B., Mazouzi, A., Suchankova, T., Konopka, T., Katz, A. M., Paz, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms13701 · Cited by 44
“%) cancers 2,4,5,12,13 .”
Targeting KRAS G12C with Covalent Inhibitors
Ostrem, J. M. L., & Shokat, K. M. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-041621-012549 · Cited by 43
The Role of the Microbiome in Pancreatic Cancer
Miyabayashi, K., Ijichi, H., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14184479 · Cited by 48
Li, M., Gao, X., & Wang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1090838 · Cited by 52
Bland, P. J., Saville, H., Wai, P. T., Curnow, L., Muirhead, G., Nieminuszczy, J., Ravindran, N., John, M. B., Hedayat, S., Barker, H. E., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01460-5 · Cited by 48
Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
Rozengurt, E., & Eibl, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02499-y · Cited by 49
Hu, Z., Zhou, S., Zhou, Z., Luo, C., Chen, E., Zhan, H., Wang, P., Dai, Z., Zhou, J., Fan, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10104 · Cited by 44
Statin use and pancreatic cancer risk in two prospective cohort studies
Hamada, T., Khalaf, N. I., Yuan, C., Babić, A., Morales‐Oyarvide, V., Qian, Z. R., Nowak, J. A., Ng, K., Kraft, P. L., Rubinson, D. A., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1430-x · Cited by 45
Duffy, D. J., Schnitzler, C. E., Karpinski, L. G., Thomas, R. S., Whilde, J., Eastman, C. B., Yang, C., Krstić, A., Rollinson, D., Zirkelbach, B., et al. (2018) · Communications Biology · doi:10.1038/s42003-018-0059-x · Cited by 45
The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer
Hasan, N. M., & Ahuja, N. (2019) · Cancers · doi:10.3390/cancers11121859 · Cited by 48
Kamyabi, N., Abbasgholizadeh, R., Maitra, A., Ardekani, A. M., Biswal, S. L., & Grande-Allen, K. J. (2020) · Biomedical Microdevices · doi:10.1007/s10544-020-00483-7 · Cited by 45
Self-citationCHD7 Expression Predicts Survival Outcomes in Patients with Resected Pancreatic Cancer
Colbert, L. E., Petrova, A. V., Fisher, S. B., Pantazides, B. G., Madden, M. Z., Hardy, C. W., Warren, M. D., Pan, Y., Nagaraju, G. P., Liu, E. A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1996 · Cited by 44
Fuentes-Fayos, A. C., Pérez‐Gómez, J. M., G-García, M. E., Jiménez‐Vacas, J. M., Blanco-Acevedo, C., Sánchez‐Sánchez, R., Solivera, J., Breunig, J. J., Gahete, M. D., Castano, J. P., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02241-4 · Cited by 43
Frankel, A. J., Armour, N., Nancarrow, D. J., Krause, L., Hayward, N. K., Lampe, G., Smithers, B. M., & Barbour, A. P. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22143 · Cited by 45
Self-citationGore, J., Imasuen, I., Conteh, A. M., Craven, K. E., Cheng, M., & Korc, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.037 · Cited by 43
Mind the (sr)GAP – roles of Slit–Robo GAPs in neurons, brains and beyond
Lucas, B. G., & Hardin, J. D. (2017) · Journal of Cell Science · doi:10.1242/jcs.207456 · Cited by 43
Splicing dysregulation as a driver of breast cancer
Read, A., & Natrajan, R. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0068 · Cited by 41
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer
Grzeskowiak, C. L., Kundu, S. T., Mo, X., Ivanov, A. A., Zagorodna, O., Lu, H., Chapple, R. H., Tsang, Y. H., Moreno, D., Mosqueda, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04572-3 · Cited by 44
Advances in oncolytic adenovirus therapy for pancreatic cancer
Nattress, C. B., & Halldén, G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.006 · Cited by 43
Robo signalling controls pancreatic progenitor identity by regulating Tead transcription factors
Escot, S., Willnow, D., Naumann, H., Francescantonio, S. D., & Spagnoli, F. M. (2018) · Nature Communications · doi:10.1038/s41467-018-07474-6 · Cited by 43
Dreyer, S. B., Jamieson, N. B., Evers, L., Duthie, F. R., Cooke, S., Marshall, J., Beraldi, D., Knight, S. R., Upstill‐Goddard, R., Dickson, E. J., et al. (2019) · Chinese Clinical Oncology · doi:10.21037/cco.2019.04.06 · Cited by 43
Self-citationT-Cell Immunity in Pancreatic Cancer
Ajina, R., & Weiner, L. M. (2020) · Pancreas · doi:10.1097/mpa.0000000000001621 · Cited by 46
Yadav, S., Kasi, P. M., Bamlet, W. R., Ho, T. P., Polley, E. C., Hu, C., Hart, S. N., Rabe, K. G., Boddicker, N. J., Gnanaolivu, R. D., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1788 · Cited by 44
Self-citationTargeting eIF4A-Dependent Translation of KRAS Signaling Molecules
Singh, K., Lin, J., Lecomte, N., Mohan, P., Gokce, A., Sanghvi, V. R., Jiang, M., Grbovic-Huezo, O., Burčul, A., Stark, S. G., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2929 · Cited by 39
Khalid, M., Idichi, T., Seki, N., Wada, M., Yamada, Y., Fukuhisa, H., Toda, H., Kita, Y., Kawasaki, Y., Tanoue, K., et al. (2019) · Cancers · doi:10.3390/cancers11030327 · Cited by 42
Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer
Laurella, L. C., Mirakian, N. T., Garcia, M. N., Grasso, D., Sülsen, V. P., & Papademetrio, D. L. (2022) · Molecules · doi:10.3390/molecules27113492 · Cited by 41
A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells
Ischenko, I., Petrenko, O., & Hayman, M. J. (2015) · Oncotarget · doi:10.18632/oncotarget.4538 · Cited by 42
Craven, K. E., Gore, J., Wilson, J. L., & Korc, M. (2015) · Oncotarget · doi:10.18632/oncotarget.6345 · Cited by 42
Duffy, D. J., Krstić, A., Halász, M., Schwarzl, T., Fey, D., Iljin, K., Mehta, J. P., Killick, K. E., Whilde, J., Turriziani, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6568 · Cited by 42
The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers
Huang, T., Kang, W., Cheng, A. S. L., Yu, J. Q., & To, K. F. (2015) · BMC Cancer · doi:10.1186/s12885-015-1984-4 · Cited by 42
Chan, E. W., Chiorean, E. G., O'Dwyer, P. J., Gabrail, N. Y., Alcindor, T., Potvin, D., Chao, R. C., & Hurwitz, H. I. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3494-3 · Cited by 42
Alcaide, M., Cheung, M. C., Bushell, K. R., Arthur, S. E., Wong, H., Karasinska, J. M., Renouf, D. J., Schaeffer, D. F., McNamara, S., du Tertre, M. C., et al. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.09.007 · Cited by 41
Precision medicine in pancreatic cancer: treating every patient as an exception
Herbst, B. T., & Zheng, L. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30175-x · Cited by 42
Koujima, T., Tazawa, H., Ieda, T., Araki, H., Fushimi, T., Shoji, R., Kuroda, S., Kikuchi, S., Yoshida, R., Umeda, Y., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.016 · Cited by 48
Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward
Franck, C., Müller, C., Rosania, R., Croner, R. S., Pech, M., & Venerito, M. (2020) · Cancers · doi:10.3390/cancers12071955 · Cited by 41
Yu, Y., Yang, G., Huang, H., Fu, Z., Cao, Z., Zheng, L., You, L., & Zhang, T. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01787-5 · Cited by 42
Aung, K. L., McWhirter, E., Welch, S. A., Wang, L. E., Lovell, S., Stayner, L.-A., Ali, S., Malpage, A., Makepeace, B., Ramachandran, M., et al. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-86 · Cited by 41
Self-citationPihlak, R., Weaver, J. M. J., Valle, J. W., & McNamara, M. G. (2018) · Cancers · doi:10.3390/cancers10010017 · Cited by 42
Topham, J. T., Tsang, E. S., Karasinska, J. M., Metcalfe, A. L., Ali, H., Kalloger, S. E., Csizmók, V., Williamson, L., Titmuss, E., Nielsen, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33718-7 · Cited by 41
Self-citationLAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth
Erice, O., Narayanan, S., Feliu, I., Entrialgo‐Cadierno, R., Malinova, A., Vicentini, C., Guruceaga, E., Delfino, P., Trajkovic‐Arsic, M., Moreno, H., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0794 · Cited by 41
Self-citationCostanzo, F. D., Costanzo, F. D., Antonuzzo, L., Mazza, E., & Giommoni, E. (2023) · Cancers · doi:10.3390/cancers15020416 · Cited by 42
Wong, M. H., Xue, A., Julovi, S. M., Pavlakis, N., Samra, J. S., Hugh, T. J., Gill, A. J., Peters, L., Baxter, R. C., & Smith, R. C. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3377 · Cited by 41
Self-citationLi, Y., & Xie, X. S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu174 · Cited by 40
Arpin, C. C., Mac, S., Jiang, Y., Cheng, H., Grimard, M., Page, B. D. G., Kamocka, M. M., Haftchenary, S., Su, H., Ball, D. P., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0003 · Cited by 42
Allaway, R. J., Fischer, D. A., Abreu, F. B. D., Gardner, T. B., Gordon, S. R., Barth, R. J., Colacchio, T. A., Wood, M. D., Kacsoh, B. Z., Bouley, S. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7718 · Cited by 41
Nguyen, T., Andrējeva, D., Gupta, R., Choudhary, C., Hong, X., Eichhorn, P. J. A., Loya, A. C., & Cohen, S. M. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.1 · Cited by 41
Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling
Humphrey, E. S., Su, S., Nagrial, A. M., Hochgräfe, F., Pajic, M., Lehrbach, G. M., Parton, R. G., Yap, A. S., Horvath, L. G., Chang, D. K.-F., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.058313 · Cited by 40
Self-citationThe Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings
Badiyan, S. N., Molitoris, J. K., Chuong, M. D., Regine, W. F., & Kaiser, A. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.01.012 · Cited by 44
Metadata
- Authors
- Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., Wu, J., Chang, D. K., Cowley, M. J., Gardiner, B. B., Song, S., Harliwong, I., Idrisoglu, S., Nourse, C., Nourbakhsh, E., Manning, S., Wani, S., Gongora, M., Pajic, M., Scarlett, C. J., Gill, A. J., Pinho, A. V., Rooman, I., Anderson, M., Holmes, O., Leonard, C., Taylor, D., Wood, S., Xu, Q., Nones, K., Lynn Fink, J., Christ, A., Bruxner, T., Cloonan, N., Kolle, G., Newell, F., Pinese, M., Scott Mead, R., Humphris, J. L., Kaplan, W., Jones, M. D., Colvin, E. K., Nagrial, A. M., Humphrey, E. S., Chou, A., Chin, V. T., Chantrill, L. A., Mawson, A., Samra, J. S., Kench, J. G., Lovell, J. A., Daly, R. J., Merrett, N. D., Toon, C., Epari, K., Nguyen, N. Q., Barbour, A., Zeps, N., Kakkar, N., Zhao, F., Qing Wu, Y., Wang, M., Muzny, D. M., Fisher, W. E., Charles Brunicardi, F., Hodges, S. E., Reid, J. G., Drummond, J., Chang, K., Han, Y., Lewis, L. R., Dinh, H., Buhay, C. J., Beck, T., Timms, L., Sam, M., Begley, K., Brown, A., Pai, D., Panchal, A., Buchner, N., De Borja, R., Denroche, R. E., Yung, C. K., Serra, S., Onetto, N., Mukhopadhyay, D., Tsao, M.-S., Shaw, P. A., Petersen, G. M., Gallinger, S., Hruban, R. H., Maitra, A., Iacobuzio-Donahue, C. A., Schulick, R. D., Wolfgang, C. L., Morgan, R. A., Lawlor, R. T., Capelli, P., Corbo, V., Scardoni, M., Tortora, G., Tempero, M. A., Mann, K. M., Jenkins, N. A., Perez-Mancera, P. A., Adams, D. J., Largaespada, D. A., Wessels, L. F. A., Rust, A. G., Stein, L. D., Tuveson, D. A., Copeland, N. G., Musgrove, E. A., Scarpa, A., Eshleman, J. R., Hudson, T. J., Sutherland, R. L., Wheeler, D. A., Pearson, J. V., McPherson, J. D., Gibbs, R. A., & Grimmond, S. M.
- Affiliations
- Garvan Institute of Medical Research (AU)
- The University of Queensland (AU)
- Ontario Institute for Cancer Research (CA)
- The University of Sydney (AU)
- Royal Adelaide Hospital (AU)
- St John of God Subiaco Hospital (AU)
- Baylor College of Medicine (US)
- University of California, Los Angeles (US)
- University Health Network (CA)
- Johns Hopkins University (US)
- University of Verona (IT)
- Houston Methodist (US)
- University of Minnesota (US)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Grimmond, Sean M.
- ORCID
- Biankin, Andrew V.
- Waddell, Nicola
- Kassahn, Karin S.
- Gingras, Marie-Claude
- Muthuswamy, Lakshmi B.
- Johns, Amber L.
- Wilson, Peter J.
- Patch, Ann-Marie
- Wu, Jianmin
- Chang, David K.
- Cowley, Mark J.
- Gardiner, Brooke B.
- Song, Sarah
- Harliwong, Ivon
- Nourbakhsh, Ehsan
- Manning, Suzanne
- Wani, Shivangi
- Pajic, Marina
- Scarlett, Christopher J.
- Gill, Anthony J.
- Pinho, Andreia V.
- Rooman, Ilse
- Anderson, Matthew
- Holmes, Oliver
- Leonard, Conrad
- Wood, Scott
- Christ, Angelika
- Cloonan, Nicole
- Newell, Felicity
- Pinese, Mark
- Kaplan, Warren
- Jones, Marc D.
- Colvin, Emily K.
- Nagrial, Adnan M.
- Chou, Angela
- Chin, Venessa T.
- Chantrill, Lorraine A.
- Mawson, Amanda
- Samra, Jaswinder S.
- Kench, James G.
- Daly, Roger J.
- Merrett, Neil D.
- Toon, Christopher
- Nguyen, Nam Q.
- Barbour, Andrew
- Zeps, Nikolajs
- Zhao, Fengmei
- Muzny, Donna M.
- Drummond, Jennifer
- Chang, Kyle
- Han, Yi
- Dinh, Huyen
- Beck, Timothy
- Begley, Kimberly
- Brown, Andrew
- Denroche, Robert E.
- Yung, Christina K.
- Serra, Stefano
- Mukhopadhyay, Debabrata
- Tsao, Ming-Sound
- Petersen, Gloria M.
- Hruban, Ralph H.
- Maitra, Anirban
- Schulick, Richard D.
- Wolfgang, Christopher L.
- Lawlor, Rita T.
- Corbo, Vincenzo
- Tortora, Giampaolo
- Tempero, Margaret A.
- Mann, Karen M.
- Jenkins, Nancy A.
- Adams, David J.
- Wessels, Lodewyk F. A.
- Rust, Alistair G.
- Stein, Lincoln D.
- Tuveson, David A.
- Scarpa, Aldo
- Eshleman, James R.
- Hudson, Thomas J.
- Wheeler, David A.
- Pearson, John V.
- McPherson, John D.
- Gibbs, Richard A.
- Grimmond, Sean M.
- Venue
- Nature
- Published
- 2012-10-24
- Volume
- 491
- Issue
- 7424
- Pages
- 399-405
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3530898
- OpenAlex
- W2161884651
- Cited by
- 2,058
- References
- 41
- Citations by year
- 2026: 62 · 2025: 98 · 2024: 90 · 2023: 128 · 2022: 173 · 2021: 190 · 2020: 168 · 2019: 163 · 2018: 159 · 2017: 187 · 2016: 191 · 2015: 176 · 2014: 157 · 2013: 113 · 2012: 1
- FWCI
- 70.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eSpace (Curtin University) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Funders
- American Association for Cancer Research
- Cancer Prevention and Research Institute of Texas (RP101353-P7, RP101353)
- Johns Hopkins University (P50CA062924)
- Royal College of Pathologists of Australasia
- Wellcome Trust
- Australian Government
- Cancer Research UK (13031)
- Australian Cancer Research Foundation
- Cancer Institute NSW
- Gastroenterological Society of Australia
- Royal Australasian College of Physicians
- Agency for Science, Technology and Research
- Petre Foundation
- Queensland Government
- R.T. Hall Trust
- Associazione Italiana per la Ricerca sul Cancro (12182, 5 x mille)
- Università degli Studi di Verona
- Ministero dello Sviluppo Economico
- National Institutes of Health (CA102701)
- Medical Research Council
- National Health and Medical Research Council (535914, 631701, 535903, 427601)
- Cancer Council NSW (SRP06-01)
- National Human Genome Research Institute (HG003273, U54HG003273)
- National Cancer Institute (CA102701, R01CA-97075, P01CA134292, P50CA101955, P50CA102701, R01CA113636, R01CA097075, P50CA062924)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic ductal adenocarcinoma, axon guidance genes, somatic mutations, copy number variation, chromatin modification, DNA repair, ATM, carcinogenesis, pathway analysis, patient survival, Sleeping Beauty transposon mutagenesis, early-stage pancreatic cancer
- MeSH terms
- Animals, Axons, Humans, Mutation, Pancreatic Neoplasms, Proteins, Signal Transduction, Gene Expression Regulation, Neoplastic, Genome, Gene Dosage, Carcinoma, Pancreatic Ductal, Mice, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
